Pictet Asset Management Holding Sa Ultragenyx Pharmaceutical Inc. Transaction History
Pictet Asset Management Holding Sa
- $88.9 Billion
- Q4 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 1,173,638 shares of RARE stock, worth $49.1 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,173,638
Previous 520,550
125.46%
Holding current value
$49.1 Million
Previous $28.9 Million
70.75%
% of portfolio
0.06%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding RARE
# of Institutions
344Shares Held
86.6MCall Options Held
675KPut Options Held
846K-
Vanguard Group Inc Valley Forge, PA10MShares$420 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$234 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.3MShares$180 Million0.57% of portfolio
-
State Street Corp Boston, MA2.72MShares$114 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.51MShares$105 Million0.01% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.93B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...